Skip to content

Clinical trials

Enrolling by invitation Pulmonary Disease, Chronic Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Status: Enrolling by invitation Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20212
20232
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VA Office of Research and Development2
Duke University1
Icahn School of Medicine at Mount Sinai1
National Institute of Allergy and Infectious Diseases (NIAID)1
OSF Healthcare System1
Paragonix Technologies1
State University of New York at Buffalo1
Strados Labs, Inc.1
Tobias Moeller-Bertram1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive10
Heart Failure4
Lung Diseases, Interstitial4
Asthma3
Lung Neoplasms3
Diabetes Mellitus2
Hypertension2
Neoplasms2
Amyotrophic Lateral Sclerosis1
Angina, Stable1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.